平衡易位携带者与不育对照相比,可用囊胚形成率或活产率未降低
该回顾性队列研究比较了单一生殖中心2012年1月至2022年8月间平衡易位携带者与年龄匹配的不育对照的体外受精结局,发现尽管易位携带者整倍体胚胎数较少,但可用囊胚形成率和活产率与对照相当,且不受携带者性别或易位类型影响。
要点
- 易位携带者与对照的囊胚形成率有统计学显著差异(59.5% vs. 62.1%),但可用囊胚形成率(47.2% vs. 50.0%)相当。
- 易位携带者与对照的活产率(63.3% vs. 66.1%)和持续种植率(71.9% vs. 75.1%)无差异。
- 男性或女性携带者、罗伯逊易位或相互易位携带者的可用囊胚形成率和活产率均与对照相当。
核心结论
- 尽管整倍体胚胎较少,平衡易位携带者的可用囊胚形成率和活产率与对照相比无差异,且不受携带者性别或易位类型影响。
- 基于这些发现,因囊胚形成失败而常规进行核型分析可能没有必要。
研究设计与样本
- 回顾性队列研究,纳入2012年1月至2022年8月单一生殖中心所有平衡易位携带者行体外受精及结构重排植入前遗传学检测的周期,并与年龄匹配的不育患者行非整倍体植入前遗传学检测的周期比较。
- 共纳入993例患者的1291个取卵周期,其中255例为易位携带者,738例为对照;易位携带者中30例(11.5%)为罗伯逊易位,231例(88.5%)为相互易位。
主要发现
- 易位携带者与对照的囊胚形成率分别为59.5%和62.1%,差异有统计学意义。
- 易位携带者与对照的可用囊胚形成率分别为47.2%和50.0%,两组相当。
- 易位携带者与对照的获卵数(18.5 vs. 18.3)、2原核胚胎数(13.4 vs. 12.5)、持续种植率(71.9% vs. 75.1%)和活产率(63.3% vs. 66.1%)均无差异。
- 男性或女性易位携带者与对照相比,可用囊胚形成率和活产率均无差异。
- 罗伯逊易位与相互易位携带者相比,囊胚形成率、可用囊胚形成率、持续种植率和活产率均相当。
临床怎么用
- 作者认为,基于这些发现,因囊胚形成失败而常规进行核型分析可能没有必要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether translocation carriers have a reduced number of usable blastocysts compared with infertile controls. DESIGN: Retrospective cohort study. SUBJECTS: All cycles of balanced translocation carriers undergoing in vitro fertilization with preimplantation genetic testing for structural rearrangements at a single infertility center compared with an age-matched control cycles of infertile patients undergoing preimplantation genetic testing for aneuploidy from January 2012 to August 2022. EXPOSURE: Balanced translocation carriers. MAIN OUTCOME MEASURES: The primary outcome measures were blastulation rate, usable blastulation rates, and live birth rate (LBR). The secondary outcome measures were sustained implantation rate, fertilization rate, number of oocytes retrieved, number of metaphase II oocytes, total blastulation failure, number of 2-pronuclear embryos, and number of euploid embryos. Outcome measures were compared between male translocation carriers and controls, female translocation carriers and controls, and Robertsonian and reciprocal translocation carriers. RESULTS: A total of 1,291 retrieval cycles from 993 patients were included, of whom 255 patients were translocation carriers, whereas 738 were controls. Of those with translocations, 30 (11.5%) were Robertsonian carriers, and 231 (88.5%) were reciprocal carriers. There was a statistically significant difference in the blastulation rate between carriers and controls (59.5% vs. 62.1%). However, usable blastulation rates (47.2% vs. 50.0%) were equivalent between groups. There were no differences in the number of oocytes retrieved (18.5 vs. 18.3), number of 2-pronuclear embryos (13.4 vs. 12.5), sustained implantation rate (71.9% vs. 75.1%), or LBR (63.3% vs. 66.1%) between translocation carriers and controls. In both male and female translocation carriers vs. controls, there were no differences in usable blastulation rates or LBRs. When comparing Robertsonian with reciprocal translocation carriers, the rates of blastulation, usable blastulation, sustained implantation, and live birth were equivalent. CONCLUSION: Despite fewer euploid embryos, there were no differences in the rates of usable blastulation or live birth in balanced translocation carriers, regardless of sex of affected partner or type of rearrangement, compared with controls. Routine karyotyping for blastulation failure may not be necessary on the basis of these findings.
引用
- Le KN, Maguire M, Puchalt NG, et al. Parental balanced translocation carriers do not have decreased usable blastulation rates or live birth rates compared with infertile controls. Fertil Steril. 2024. PMID: 39542124. doi:10.1016/j.fertnstert.2024.11.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。